about
Safe handling of oral antineoplastic medications: focus on targeted therapeutics in the home settingHematologic malignancies during pregnancy: A reviewSuccessful Management of Pregnancy and Hepatic Toxicity in a CML Female Patient Treated with Nilotinib: a Case Report and a Review.Chronic-phase chronic myeloid leukemia: Not always a reassuring diagnosis.The impact of dasatinib on pregnancy outcomes.Managing pregnancy in chronic myeloid leukaemia.Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports.Placental transfer of tyrosine kinase inhibitors used for chronic myeloid leukemia treatment.Recognizing Endocrinopathies Associated With Tyrosine Kinase Inhibitor Therapy in Children With Chronic Myelogenous Leukemia.Management of pregnant chronic myeloid leukemia patients.BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia.Recurrence of Chronic Myeloid Leukemia during Pregnancy Subsequently Achieving Complete Medical Remission.Obstetric Complications and Management in Chronic Myeloid Leukemia.Management of chronic myeloid leukemia in the setting of pregnancy: when is leukocytapheresis appropriate? A case report and review of the literature.Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib.Experience with dasatinib and nilotinib use in pregnancy.Fertility preservation for patients with hematologic malignancies: The Korean Society for Fertility Preservation clinical guidelines.Pregnancy on vandetanib in metastatic medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2B.Melanoma and pregnancy.Breastfeeding in Patients with Chronic Myeloid Leukaemia: Case Series with Measurements of Drug Concentrations in Maternal Milk and Literature Review.Pregnancy: part of life in chronic myelogenous leukemia.
P2860
Q23923997-4EAE376C-3AD6-4B1F-8C8C-DDBE8A5D7CF1Q26740587-466657F5-3F3F-401C-B96C-8A710A43E6FEQ35130023-7571BC83-251E-4486-A722-8B9C95EDD9AAQ35925580-9F128260-271F-487A-92BA-7137F40488DBQ37423501-A156553E-66DF-47EA-9AC6-B7DC13E338A2Q38392686-A9F97EE9-7995-482D-B4BC-7E08758D8F88Q38666371-ACD74272-3873-4405-A2FB-BAF4388DF77AQ38681424-1DB12F37-C94D-40C8-89B1-9089CEE5B570Q38813874-EE7656B9-68DF-4320-B19A-B86D25921DF8Q38879793-CBF3117C-6987-44D5-82A1-1FABD15D056AQ39350678-ABE18950-517D-4CA6-9880-0643B41E5ED2Q41439633-CED5E856-680C-4E91-94E8-E84E73C323C5Q42136451-CC3DCCFF-DD73-4FF4-B573-40EAAC71A2E8Q46018403-B861F24A-606E-4817-914A-42DD29B72919Q46461016-23720CB1-0BC9-401E-8EEF-85DA58E0DA64Q47238424-1B537CB4-FC81-4820-92E7-A3E35F2E6C70Q49627384-2053A43A-5513-431B-8499-DCE807B5D032Q49861512-F88CFD1B-267C-4362-89B3-942E4E7D6B74Q52726498-116980B2-A8B4-4540-87EC-5F08762A9581Q54110129-9722B09F-C66E-4E5E-8334-8587AD169CD1Q54186045-9FE46F0C-9999-421B-B2E6-E13A612D3E00
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tyrosine kinase inhibitors and pregnancy.
@ast
Tyrosine kinase inhibitors and pregnancy.
@en
Tyrosine kinase inhibitors and pregnancy.
@nl
type
label
Tyrosine kinase inhibitors and pregnancy.
@ast
Tyrosine kinase inhibitors and pregnancy.
@en
Tyrosine kinase inhibitors and pregnancy.
@nl
prefLabel
Tyrosine kinase inhibitors and pregnancy.
@ast
Tyrosine kinase inhibitors and pregnancy.
@en
Tyrosine kinase inhibitors and pregnancy.
@nl
P2860
P356
P1476
Tyrosine kinase inhibitors and pregnancy.
@en
P2093
Alessio Pio Perrotti
Malgorzata Monika Trawinska
P2860
P304
P356
10.4084/MJHID.2014.028
P577
2014-04-07T00:00:00Z